08048035996
Trulicity 0.75mg Good Quality Pen Injection to UK - London | Phoenix Exim | Trusted Exporter

1. General Information

Trulicity 0.75 mg is a prescription injectable medicine containing dulaglutide. It is administered once weekly by subcutaneous injection and is intended to be used as part of an overall diabetes-management plan that includes appropriate diet and physical activity. It is not insulin and should not be used for type 1 diabetes.

For Phoenix Exim, it can be described as a pharmaceutical product supplied from Nagpur, India, with intended export markets including the USA, UK, Australia, Singapore, Canada, South Korea and UAE, subject to each destination country's prescription and import regulations.

2. Product Information

  • Brand: Trulicity
  • Active ingredient: Dulaglutide
  • Strength: 0.75 mg/0.5 mL
  • Dosage form: Injection
  • Device: Single-dose prefilled pen
  • Drug class: GLP-1 receptor agonist
  • Route: Subcutaneous injection
  • Frequency: Once weekly
  • Prescription status: Prescription medicine

3. Uses of Trulicity 0.75 mg

Trulicity is used:

  • To improve blood-glucose control in type 2 diabetes along with diet and exercise.
  • In adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors, to reduce the risk of major cardiovascular events such as cardiovascular death, nonfatal heart attack and nonfatal stroke.

4. Benefits of This Medicine

Potential clinical benefits include:

  • Helps improve blood-glucose control.
  • Supports reduction of HbA1c when used as prescribed.
  • The once-weekly dosing schedule can make treatment convenient.
  • In certain adults with type 2 diabetes, it provides cardiovascular risk-reduction benefits.
  • It can be used without regard to meals.

Important: Trulicity is not approved as a weight-loss medicine. Although weight loss can occur in some patients, it should not be promoted as a dedicated weight-management treatment.

5. Side Effects of Trulicity

Possible adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, abdominal pain, decreased appetite and indigestion. More serious reactions can also occur, including pancreatitis, serious allergic reactions, hypoglycemia when combined with certain diabetes medicines, and severe gastrointestinal reactions.

6. Common Side Effects

The commonly reported side effects include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal pain
  • Decreased appetite
  • Indigestion
  • Fatigue

Nausea is particularly common when treatment is started and may improve with continued treatment.

7. How to Use Trulicity 0.75 mg

Trulicity should be used exactly as prescribed by a healthcare professional.

The standard adult starting dose is 0.75 mg once weekly, administered under the skin of the abdomen, thigh or upper arm. It can be administered at any time of day, with or without food.

The pen should be used according to the manufacturer's Instructions for Use. It should not be injected into a vein or muscle, and the pen should not be shared with another person.

8. How This Medicine Works

Dulaglutide is a GLP-1 receptor agonist. It mimics the activity of the naturally occurring GLP-1 hormone. It helps the body release insulin when blood glucose is elevated, reduces inappropriate glucagon secretion and slows gastric emptying. Together, these actions help lower blood glucose.

9. Safety Advice

  • Use only under medical supervision and according to the prescription.
  • Do not use Trulicity if you or a family member has a history of medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Seek medical attention for severe or persistent abdominal pain, particularly if it may indicate pancreatitis.
  • Watch for symptoms of serious allergic reactions such as facial/throat swelling or difficulty breathing.
  • Hypoglycemia risk can increase when Trulicity is used with insulin or sulfonylureas.
  • Severe gastrointestinal reactions can occur.
  • Tell your healthcare provider about other medicines because Trulicity can delay gastric emptying and potentially affect absorption of some oral medicines.
  • Discuss pregnancy, planned pregnancy or breastfeeding with your healthcare provider before treatment.
  • Store and handle the pen according to the product's official storage instructions.

10. FAQs

Q1. What is Trulicity 0.75 mg?
Trulicity 0.75 mg is a once-weekly injectable medicine containing dulaglutide for type 2 diabetes.

Q2. How often is Trulicity 0.75 mg taken?
It is generally administered once weekly. The prescribed day should be followed consistently.

Q3. Is Trulicity insulin?
No. Trulicity is a GLP-1 receptor agonist and is not insulin.

Q4. Can Trulicity be used for type 1 diabetes?
No. It is indicated for type 2 diabetes, not type 1 diabetes.

Q5. Can Trulicity be taken with food?
Yes. It can be administered at any time of day, with or without food.

Q6. Where is Trulicity injected?
It is injected subcutaneously into the abdomen, thigh or upper arm.

Q7. What happens if a dose is missed?
According to the current U.S. prescribing information, a missed dose may be taken as soon as possible if there are at least 72 hours (3 days) before the next scheduled dose.

Q8. Does Trulicity cause weight loss?
Weight reduction can occur in some patients, but Trulicity is indicated for type 2 diabetes and cardiovascular risk reduction in specified adults—not as a dedicated weight-loss medicine.

11. Substitutes / Alternatives

There is no universal one-to-one substitute for Trulicity. Depending on the patient's condition, a healthcare professional may consider other GLP-1 receptor agonists or other glucose-lowering medicines.

Examples of medicines in related treatment areas include semaglutide (Ozempic/Rybelsus), liraglutide (Victoza), and exenatide products, but these are not direct dose-for-dose substitutes for dulaglutide. The appropriate alternative depends on the patient's diabetes control, cardiovascular status, kidney function, other medicines, tolerability and local approvals.

12. SEO Keywords for Phoenix Exim

Primary keywords:

  • Trulicity 0.75 mg Pen Injection exporter from India
  • Trulicity 0.75 mg supplier from Nagpur India
  • Dulaglutide 0.75 mg injection exporter
  • Trulicity 0.75 mg prefilled pen supplier
  • Trulicity 0.75 mg wholesale supplier India
  • Dulaglutide injection pharmaceutical exporter India
  • Trulicity 0.75 mg medicine exporter
  • Trulicity 0.75 mg pen injection supplier
  • Genuine Trulicity 0.75 mg supplier India
  • Trulicity 0.75 mg pharmaceutical distributor India

Long-tail B2B keywords:

  • Buy Trulicity 0.75 mg pen injection from India
  • Trulicity 0.75 mg pen injection wholesale exporter from Nagpur
  • Dulaglutide 0.75 mg injection wholesale pharmaceutical supplier
  • Trulicity 0.75 mg prefilled pen international medicine supplier
  • Trulicity 0.75 mg diabetes injection exporter from India
  • Trulicity 0.75 mg bulk pharmaceutical supplier India
  • Trulicity 0.75 mg pen exporter to USA from India
  • Trulicity 0.75 mg supplier for UK pharmaceutical buyers
  • Dulaglutide 0.75 mg exporter to Australia from India
  • Trulicity 0.75 mg supplier for Singapore pharmaceutical market
  • Trulicity 0.75 mg exporter to Canada from India
  • Trulicity 0.75 mg pharmaceutical supplier for South Korea
  • Dulaglutide 0.75 mg exporter to UAE from India
  • Trulicity 0.75 mg B2B medicine supplier from Nagpur India
  • Prescription diabetes medicine exporter from India to international markets
Aug 13th, 2026 3:38 PM

Keywords